A Combined Treatment with Taurine and Intra-arterial Thrombolysis in an Embolic Model of Stroke in Rats: Increased Neuroprotective Efficacy and Extended Therapeutic Time Window

Translational Stroke Research

Volumn 2, Issue 1, 2011, Pages 80-91

  Guan, Weihua ^a   Zhao, Yumei ^a   Xu, Chao ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cerebral ischemia; Neuroprotection; Rat; Taurine; Thrombolysis; Urokinase

Indexed keywords

MYELOPEROXIDASE; TAURINE; UROKINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; COGNITION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENTIATION; FIBRINOLYTIC THERAPY; LOW DRUG DOSE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

EID: 79951514009     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-010-0050-4     Document Type: Article

References (41)

1. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4. 5 h after acute ischemic stroke. N Engl J Med. 2008; 359: 1317-29.
2. Macleod MR, Davis SM, Mitchell PJ, Gerraty RP, Fitt G, Hankey GJ, et al. Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovasc Dis. 2005; 20: 12-7.
3. Agarwal P, Kumar S, Hariharan S, Eshkar N, Verro P, Cohen B, et al. Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke? Cerebrovasc Dis. 2004; 17: 182-90.
4. Qureshi AI, Ezzeddine MA, Nasar A, Suri MF, Kirmani JF, Janjua N, et al. Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign? Neurology. 2006; 66(8): 1171-4.
5. Labiche LA, Al-Senani F. WojnerAW, et al. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study. Stroke. 2003; 34: 695-8.
6. Alexandrov AV, Molina CA, Grotta JC, et al. Ultrasound enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med. 2004; 351: 2170-8.
7. Brott TG, Haley Jr EC, Levy DE, et al. Urgent therapy for stroke. Part 1. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke. 1992; 23: 632-40.
8. Von Krummer R, Hacke W. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke. 1992; 23: 646-52.
9. Trouillas P, Nighoghossian N, Getenet JC, et al. Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke: correlations of outcome with clinical and radiological data. Stroke. 1996; 27: 882-90.
10. Mattle HP. Intravenous or intra-arterial thrombolysis? It's time to find the right approach for the right patient. Stroke. 2007; 38: 2038-40.
11. Del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke. 1998; 29: 4-11.
12. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial pro-urokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial. JAMA. 1999; 282: 2003-11.
13. Zhang L, Zhang ZG, Zhang CL, Zhang RL, Chopp M. Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model. Stroke. 2004; 35: 2890-095.
14. Sun M, Xu C. Neuroprotective mechanism of taurine due to up-regulating calpastatin and down-regulating calpain and caspase-3 during focal cerebral ischemia cellular and molecular neurobiology. Cell Mol Neurobiol. 2008; 28: 593-611.
15. Asahi M, Asahi K, Wang XY, Lo EH. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 2000; 20: 452-7.
16. Paxinos G, Watson C. The Rat Brain Stereotaxic Coordinates. 2nd ed. Orlando: Academic Press; 1986.
17. Shuaib A, Yang Y, Siddiqui M, Kalra J. Intraarterial urokinase produces significant attenuation of infarction volume in an embolic focal ischemia model. Exp Neurol. 1998; 154: 330-5.
18. Yang Y, Li Q, Shuaib A. Enhanced neuroprotection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate. Neuropharmacology. 2000; 39: 881-8.
19. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986; 17: 472-6.
20. Lin TN, He YY, Wu G, Khan M, Hsu CY. Effects of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke. 1993; 24: 117-21.
21. Zhang JW, Gottschall PE. Zymographic measurement of gelatinase activity in brain tissue after detergent extraction and affinity-support purification. J Neurosci Methods. 1997; 76: 15-20.
22. Kleiner DE, Stetler-Stevenson WG. Quantitative zymography: detection of pictogram quantities of gelatinase. Anal Biochem. 1994; 218: 325-9.
23. Zhang ZG, Chopp M. Measurement of myeloperoxidase immunoreactive cells in ischemic brain after transient middle cerebral artery occlusion in the rat. Neurosci Res Comm. 1997; 20: 85-91.
24. Lima L, Obregon F, Cubillos S, Fazzino F, Jaimes I. Taurine as a micronutrient in development and regeneration of the central nervous system. Nutr Neurosci. 2001; 4: 439-43.
25. Matsumoto K, Ueda S, Hashimoto T, Kuriyama K. Ischemic neuronal injury in the rat hippocampus following transient forebrain ischemia: evaluation using in vivo microdialysis. Brain Res. 1991; 543: 236-42.
26. Wu JY, Lin CT, Johanssen FF, Liu JW. Taurine neurons in rat hippocampal formation are relatively inert to cerebral ischemia. Adv Exp Med Biol. 1994; 359: 289-98.
27. Shuaib A. The role of taurine in cerebral ischemia: studies in transient forebrain ischemia and embolic focal ischemia in rodents. Adv Exp Med Biol. 2003; 526: 421-31.
28. Sanberg PR, Willow M. Dose-dependent effects of taurine on convulsions induced by hypoxia in the rat. Neurosci Lett. 1980; 16: 297-300.
29. Schurr A, Tseng MT, West CA, Rigor BM. Taurine improves the recovery of neuronal function following cerebral hypoxia: an in vitro study. Life Sci. 1987; 40: 2059-66.
30. Schuller-Levis GB, Park E. Taurine and its chloramine: modulators of immunity. Neurochem Res. 2004; 29: 117-26.
31. Guz G, Oz E, Lortlar N, Ulusu NN, Demirogullari B, Omeroglu S, et al. The effect of taurine on renal ischemia/reperfusion injury. Amino Acids. 2007; 32: 405-11.
32. Raschke P, Massoudy P, Becker BF. Taurine protects the heart from neutrophil-induced reperfusion injury. Free Radic Biol Med. 1995; 19: 461-71.
33. Giriş M, Depboylu B, Doǧru-Abbasoǧlu S, Erbil Y, Olgaç V, Aliş H, et al. Effect of taurine on oxidative stress and apoptosis-related protein expression in trinitrobenzene sulphonic acid-induced colitis. Clin Exp Immunol. 2008; 152: 102-10.
34. Marcinkiewicz J, Kurnyta M, Biedroń R, Bobek M, Kontny E, Maśliński W. Anti-inflammatory effects of taurine derivatives (taurine chloramine, taurine bromamine, and taurolidine) are mediated by different mechanisms. Adv Exp Med Biol. 2006; 583: 481-92.
35. Zhao RZ, Wang S, Kim HY, Storrie H, Rosen BR, Mooney DJ, et al. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med. 2006; 12: 441-5.
36. Gidday JM, Gasche YG, Copin JC, Shah AR, Perez RS, Shapiro SD, et al. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am J Physiol Heart Circ Physiol. 2005; 289: H558-68.
37. Matsuo Y, Onodera H, Shiga Y, Nakamura M, Ninomiya M, Kihara T, et al. Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion. Stroke. 1994; 25: 1469-75.
38. Ogawa A, Mori E, Minematsu K, Taki W, Takahashi A, Nemoto S, et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke. 2007; 38(10): 2633-9.
39. Lee DH, Jo KD, Kim HG, Choi SJ, Jung SM, Ryu DS, et al. Local intraarterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab: a pilot study. J Vasc Interv Radiol. 2002; 13(8): 769-74.
40. Yu YY, Niu L, Gao L, Zhao ZW, Deng JP, Qu YZ, et al. Intraarterial thrombolysis and stent placement for acute basilar artery occlusion. J Vasc Interv Radiol. 2010; 21(9): 1359-63.
41. Arnold M, Fischer U, Schroth G, Nedeltchev K, Isenegger J, Remonda L, et al. Intra-arterial thrombolysis of acute iatrogenic intracranial arterial occlusion attributable to neuroendovascular procedures or coronary angiography. Stroke. 2008; 39(5): 1491-5.